Ratings by Roth/MKM (Max Masucci)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/22/2026 | Natera | NTRA | New Coverage | Buy (N/A) |
413.38 (404.23) |
-2.21% | Details | |
| 10/22/2026 | Guardant Health | GH | New Coverage | Buy (N/A) |
166.66 (174.53) |
4.72% | Details | |
| 9/29/2026 | Nautilus Biotechnology | NAUT | New Coverage | Buy (N/A) |
0.96 (2.53) |
163.54% | Details | |
| 9/29/2026 | Rapid Micro Biosystems Inc | RPID | New Coverage | Buy (N/A) |
1.11 (0.78) |
-29.73% | Details | |
| 8/5/2026 | Alpha Teknova Inc. | TKNO | New Coverage | Buy (N/A) |
5.30 (6.60) |
24.53% | Details | |
| 8/4/2026 | Exagen | XGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2026 | 908 Devices Inc. | MASS | New Coverage | Buy (N/A) |
7.13 (11.76) |
64.94% | Details | |
| 6/24/2026 | Biodesix | BDSX | New Coverage | Buy (N/A) |
19.16 (21.37) |
11.53% | Details | |
| 6/24/2026 | Castle Biosciences | CSTL | New Coverage | Buy (N/A) |
21.38 (33.23) |
55.43% | Details | |
| 6/24/2026 | Exagen | XGN | New Coverage | Buy (N/A) |
4.36 (7.39) |
69.5% | Details |
